Showing 201 - 220 results of 760 for search 'Miss Universe Japan', query time: 0.16s Refine Results
  1. 201

    Continuing Pharmacy Education: Exploring the Status and Future Prospects in Nepal by Khatiwada AP, Shrestha S, Sapkota B, Shakya S, Shrestha R, Roien R, Ozaki A, Mohamed Ibrahim MI

    Published 2022-04-01
    “…Asmita Priyadarshini Khatiwada,1 Sunil Shrestha,1,2 Binaya Sapkota,2 Sujyoti Shakya,1 Rajeev Shrestha,3 Rohullah Roien,4 Akihiko Ozaki,5 Mohamed Izham Mohamed Ibrahim6 1Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal; 2Nobel College Faculty of Health Sciences, Affiliated to Pokhara University, Kathmandu, Province Bagmati, Nepal; 3Department of Pharmacy, District Hospital Lamjung, Lamjung, Nepal; 4Medical Research Centre, Kateb University, Kabul, Afghanistan; 5Medical Governance Research Institute, Tokyo, Japan; 6Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha, QatarCorrespondence: Asmita Priyadarshini Khatiwada, Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal, Email asmitapriyadarshinikhatiwada@gmail.com Rohullah Roien, Medical Research Centre, Kateb University, Kabul, Afghanistan, Email rohullahroien@kateb.edu.afAbstract: Continuing pharmacy education (CPE) is an educational way for pharmacy professionals to develop competency in providing quality pharmaceutical care to patients. …”
    Get full text
    Article
  2. 202
  3. 203
  4. 204

    Comparing proton momentum distributions in A = 2 and 3 nuclei via 2H 3H and 3He (e,e′p) measurements by R. Cruz-Torres, S. Li, F. Hauenstein, A. Schmidt, D. Nguyen, D. Abrams, H. Albataineh, S. Alsalmi, D. Androic, K. Aniol, W. Armstrong, J. Arrington, H. Atac, T. Averett, C. Ayerbe Gayoso, X. Bai, J. Bane, S. Barcus, A. Beck, V. Bellini, H. Bhatt, D. Bhetuwal, D. Biswas, D. Blyth, W. Boeglin, D. Bulumulla, A. Camsonne, J. Castellanos, J.-P. Chen, E.O. Cohen, S. Covrig, K. Craycraft, B. Dongwi, M. Duer, B. Duran, D. Dutta, E. Fuchey, C. Gal, T.N. Gautam, S. Gilad, K. Gnanvo, T. Gogami, J. Gomez, C. Gu, A. Habarakada, T. Hague, O. Hansen, M. Hattawy, O. Hen, D.W. Higinbotham, E. Hughes, C. Hyde, H. Ibrahim, S. Jian, S. Joosten, A. Karki, B. Karki, A.T. Katramatou, C. Keppel, M. Khachatryan, V. Khachatryan, A. Khanal, D. King, P. King, I. Korover, T. Kutz, N. Lashley-Colthirst, G. Laskaris, W. Li, H. Liu, N. Liyanage, D. Lonardoni, R. Machleidt, L.E. Marcucci, P. Markowitz, R.E. McClellan, D. Meekins, S. Mey-Tal Beck, Z.-E. Meziani, R. Michaels, M. Mihovilovič, V. Nelyubin, N. Nuruzzaman, M. Nycz, R. Obrecht, M. Olson, L. Ou, V. Owen, B. Pandey, V. Pandey, A. Papadopoulou, S. Park, M. Patsyuk, S. Paul, G.G. Petratos, E. Piasetzky, R. Pomatsalyuk, S. Premathilake, A.J.R. Puckett, V. Punjabi, R. Ransome, M.N.H. Rashad, P.E. Reimer, S. Riordan, J. Roche, F. Sammarruca, N. Santiesteban, B. Sawatzky, E.P. Segarra, B. Schmookler, A. Shahinyan, S. Širca, N. Sparveris, T. Su, R. Suleiman, H. Szumila-Vance, A.S. Tadepalli, L. Tang, W. Tireman, F. Tortorici, G. Urciuoli, M. Viviani, L.B. Weinstein, B. Wojtsekhowski, S. Wood, Z.H. Ye, Z.Y. Ye, J. Zhang

    Published 2019-10-01
    Get full text
    Article
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212

    Clinical utility of the Oncomine Dx Target Test multi‐CDx system and the possibility of utilizing those original sequence data by Ayaka Saito, Hideki Terai, Tae‐Jung Kim, Katsura Emoto, Ryutaro Kawano, Kohei Nakamura, Hideyuki Hayashi, Hatsuyo Takaoka, Akihiko Ogata, Katsuhito Kinoshita, Fumimaro Ito, Lisa Shigematsu, Masahiko Okada, Takahiro Fukushima, Akifumi Mitsuishi, Taro Shinozaki, Keiko Ohgino, Shinnosuke Ikemura, Hiroyuki Yasuda, Ichiro Kawada, Kenzo Soejima, Hiroshi Nishihara, Koichi Fukunaga

    Published 2024-02-01
    “…Additionally, we confirmed comparable instances of overlook results for EGFR mutations in the dataset from South Korea, implying that this type of oversight could occur in other countries using the ODxTT. EGFR mutation was missed in ODxTT in Japan (6.3%, 2/32), South Korea (2.0%, 1/49), and overall (3.7%, 3/81). …”
    Get full text
    Article
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220